GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Bcl2 | decreases expression | EXP | | 6480464 | CTD | Dexamethasone results in decreased expression of BCL2 mRNA; Dexamethasone results in decreased expression of BCL2 protein | PMID:16644695 PMID:30878453 PMID:7517174 | Bcl2 | decreases response to substance | EXP | | 6480464 | CTD | BCL2 protein results in decreased susceptibility to Dexamethasone | PMID:19997594 | Bcl2 | increases expression | EXP | | 6480464 | CTD | Dexamethasone results in increased expression of BCL2 mRNA | PMID:21041162 | Bcl2 | multiple interactions | EXP | | 6480464 | CTD | [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine co-treated with [Dexamethasone co-treated with INS protein co-treated with PRL protein]] results in increased expression of BCL2 protein; BCL2 gene inhibits the reaction [Dexamethasone results in decreased activity of CAT protein]; BCL2 gene inhibits the reaction [Dexamethasone results in decreased activity of NQO1 protein]; Dexamethasone inhibits the reaction [Lipopolysaccharides results in decreased expression of BCL2 protein]; Mifepristone inhibits the reaction [Dexamethasone results in decreased expression of BCL2 mRNA]; Mifepristone inhibits the reaction [Dexamethasone results in decreased expression of BCL2 protein]; naringin inhibits the reaction [Dexamethasone results in decreased expression of BCL2 protein] | PMID:11751460 PMID:16644695 PMID:17180084 PMID:30878453 PMID:32687258 | Bcl2 | decreases expression | ISO | Bcl2 (Rattus norvegicus) | 6480464 | CTD | Dexamethasone results in decreased expression of BCL2 mRNA; Dexamethasone results in decreased expression of BCL2 protein | PMID:19080409 PMID:30506661 | Bcl2 | decreases response to substance | ISO | BCL2 (Homo sapiens) | 6480464 | CTD | BCL2 protein results in decreased susceptibility to Dexamethasone | PMID:16505121 | Bcl2 | increases expression | ISO | Bcl2 (Rattus norvegicus) | 6480464 | CTD | Dexamethasone results in increased expression of BCL2 protein | PMID:11319611 | Bcl2 | increases expression | ISO | BCL2 (Homo sapiens) | 6480464 | CTD | Dexamethasone results in increased expression of BCL2; Dexamethasone results in increased expression of BCL2 protein | PMID:11319611 PMID:21244764 | Bcl2 | increases response to substance | ISO | BCL2 (Homo sapiens) | 6480464 | CTD | BCL2 protein results in increased susceptibility to Dexamethasone | PMID:10200551 | Bcl2 | multiple interactions | ISO | Bcl2 (Rattus norvegicus) | 6480464 | CTD | Dexamethasone inhibits the reaction [Dehydroepiandrosterone results in increased expression of BCL2 protein]; fludarabine inhibits the reaction [Dexamethasone results in decreased expression of BCL2 protein] | PMID:16407456 PMID:30506661 | Bcl2 | multiple interactions | ISO | BCL2 (Homo sapiens) | 6480464 | CTD | [Doxorubicin co-treated with Dexamethasone co-treated with Vincristine co-treated with Cytarabine co-treated with Mercaptopurine co-treated with Methotrexate co-treated with Cyclophosphamide co-treated with Enzymes and Coenzymes] results in increased expression of BCL2 protein; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of BCL2 mRNA; [oblimersen co-treated with Thalidomide co-treated with Dexamethasone] results in decreased expression of BCL2 mRNA; [oblimersen co-treated with Thalidomide co-treated with Dexamethasone] results in decreased expression of BCL2 protein; Dexamethasone inhibits the reaction [Cisplatin results in decreased expression of BCL2 mRNA]; Dexamethasone inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein]; Dexamethasone inhibits the reaction [TNF protein results in increased expression of BCL2 mRNA]; Mifepristone inhibits the reaction [Dexamethasone results in increased expression of BCL2]; Mycophenolic Acid inhibits the reaction [BCL2 protein results in decreased susceptibility to Dexamethasone] | PMID:15867202 PMID:16505121 PMID:21182165 PMID:21244764 PMID:21420233 PMID:21940343 PMID:28628672 | |
Go Back to source page | Continue to Ontology report |